SG11201805611RA - Porcine reproductive and respiratory syndrome vaccine virus - Google Patents

Porcine reproductive and respiratory syndrome vaccine virus

Info

Publication number
SG11201805611RA
SG11201805611RA SG11201805611RA SG11201805611RA SG11201805611RA SG 11201805611R A SG11201805611R A SG 11201805611RA SG 11201805611R A SG11201805611R A SG 11201805611RA SG 11201805611R A SG11201805611R A SG 11201805611RA SG 11201805611R A SG11201805611R A SG 11201805611RA
Authority
SG
Singapore
Prior art keywords
international
viruses
indiana
rule
eli lilly
Prior art date
Application number
SG11201805611RA
Other languages
English (en)
Inventor
Ying Fang
Stephen Wu
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of SG11201805611RA publication Critical patent/SG11201805611RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C12N2770/10064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201805611RA 2016-02-18 2017-02-10 Porcine reproductive and respiratory syndrome vaccine virus SG11201805611RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662296658P 2016-02-18 2016-02-18
PCT/US2017/017290 WO2017142798A1 (en) 2016-02-18 2017-02-10 Porcine reproductive and respiratory syndrome vaccine virus

Publications (1)

Publication Number Publication Date
SG11201805611RA true SG11201805611RA (en) 2018-07-30

Family

ID=58057334

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805611RA SG11201805611RA (en) 2016-02-18 2017-02-10 Porcine reproductive and respiratory syndrome vaccine virus

Country Status (17)

Country Link
US (2) US10155035B2 (zh)
EP (1) EP3416682A1 (zh)
JP (2) JP6840159B2 (zh)
KR (4) KR20180100231A (zh)
CN (1) CN108697787B (zh)
AU (2) AU2017219594B2 (zh)
BR (1) BR112018015912A2 (zh)
CA (2) CA3081982A1 (zh)
CL (2) CL2018002123A1 (zh)
CO (1) CO2018008184A2 (zh)
EA (1) EA201891555A1 (zh)
MX (2) MX2018009956A (zh)
NZ (1) NZ744054A (zh)
PH (1) PH12018501750A1 (zh)
SG (1) SG11201805611RA (zh)
TW (2) TWI652347B (zh)
WO (1) WO2017142798A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI652347B (zh) * 2016-02-18 2019-03-01 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒
MX2021015938A (es) * 2019-08-29 2022-04-26 Elanco Us Inc Virus para vacuna contra el síndrome respiratorio y reproductivo porcino.
CN113151493B (zh) * 2021-04-01 2023-09-15 吉林省养蜂科学研究所（吉林省蜂产品质量管理监督站、吉林省蜜蜂遗传资源基因保护中心） 一种长白山东方蜜蜂ssr标记引物组、pcr鉴定方法以及应用
CN114292961A (zh) * 2022-01-29 2022-04-08 龙岩学院 鉴定类nadc-30毒株的实时荧光rt-pcr检测引物和探针组

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000065032A1 (en) 1999-04-22 2000-11-02 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
CN103695465A (zh) * 2013-12-16 2014-04-02 中国农业科学院哈尔滨兽医研究所 猪繁殖与呼吸综合征病毒疫苗株cDNA感染性克隆及其应用
EP3119429A4 (en) * 2014-03-21 2018-04-04 Nutech Ventures A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using
TWI652347B (zh) * 2016-02-18 2019-03-01 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒

Also Published As

Publication number Publication date
JP7053552B2 (ja) 2022-04-12
KR102553823B1 (ko) 2023-07-07
TWI704225B (zh) 2020-09-11
KR20220027292A (ko) 2022-03-07
CN108697787B (zh) 2023-01-10
PH12018501750A1 (en) 2019-05-15
EP3416682A1 (en) 2018-12-26
JP2019505217A (ja) 2019-02-28
BR112018015912A2 (pt) 2019-01-22
CN108697787A (zh) 2018-10-23
EA201891555A1 (ru) 2019-01-31
AU2019203817A1 (en) 2019-06-20
CA3014615A1 (en) 2017-08-24
MX2022008809A (es) 2022-08-11
NZ744054A (en) 2020-03-27
CO2018008184A2 (es) 2018-08-21
AU2017219594B2 (en) 2019-06-27
AU2017219594A1 (en) 2018-07-19
JP6840159B2 (ja) 2021-03-10
AU2019203817B2 (en) 2020-05-21
KR20200049905A (ko) 2020-05-08
TW201738374A (zh) 2017-11-01
US20190022208A1 (en) 2019-01-24
KR20200072565A (ko) 2020-06-22
KR20180100231A (ko) 2018-09-07
US20170239343A1 (en) 2017-08-24
KR102553821B1 (ko) 2023-07-07
WO2017142798A1 (en) 2017-08-24
TWI652347B (zh) 2019-03-01
CL2018002123A1 (es) 2018-11-23
US10300126B2 (en) 2019-05-28
MX2018009956A (es) 2018-11-29
CA3081982A1 (en) 2017-08-24
TW201907006A (zh) 2019-02-16
CL2021003211A1 (es) 2022-08-05
US10155035B2 (en) 2018-12-18
JP2020036593A (ja) 2020-03-12

Similar Documents

Publication Publication Date Title
SG11201807912SA (en) Vaccine against rsv
SG11201804411TA (en) Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof
SG11201909955XA (en) Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201806863WA (en) Tetracyclic pyridone compounds as antivirals
SG11201811432WA (en) Rna for cancer therapy
SG11201903021WA (en) Anti-human 4-1 bb antibodies and use thereof
SG11201810048VA (en) Tri-segmented pichinde viruses as vaccine vectors
SG11201906297QA (en) Nucleic acids encoding crispr-associated proteins and uses thereof
SG11201901206SA (en) Trimer stabilizing hiv envelope protein mutations
SG11201806340YA (en) Zika virus vaccine
SG11201900844UA (en) Amino pyrimidine ssao inhibitors
SG11201807051VA (en) Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human flt3l or gm-csf for cancer immunotherapy
SG11201908330PA (en) Farnesoid x receptor agonists and uses thereof
SG11201811363YA (en) Anti-zika virus antibodies and methods of use
SG11201807279QA (en) Binding proteins and methods of use thereof
SG11201805229YA (en) Means and methods for treating hbv
SG11201809700YA (en) Gdf15 fusion proteins and uses thereof
SG11201907032RA (en) Amino pyrimidine compounds useful as ssao inhibitors
SG11201805001UA (en) Method of treating influenza a
SG11201909011PA (en) Niraparib compositions
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201900845YA (en) Uses of il-13 antagonists for treating atopic dermatitis
SG11202000312UA (en) Encapsulated polynucleotides and methods of use
SG11201908326YA (en) Methods of treating neurodegenerative diseases